C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity

被引:1000
作者
Dempsey, PW
Allison, MED
Akkaraju, S
Goodnow, CC
Fearon, DT
机构
[1] UNIV CAMBRIDGE,SCH MED,DEPT MED,WELLCOME TRUST IMMUNOL UNIT,CAMBRIDGE CB2 2SP,ENGLAND
[2] STANFORD UNIV,SCH MED,PROGRAM IMMUNOL,STANFORD,CA 94305
[3] STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
基金
英国惠康基金;
关键词
D O I
10.1126/science.271.5247.348
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
An optimal immune response should differentiate between harmful and innocuous antigens. Primitive systems of innate immunity, such as the complement system, may play a role in this distinction. When activated, the C3 component of complement attaches to potential antigens on microorganisms. To determine whether this alters acquired immune recognition, mice were immunized with a recombinant model antigen, hen egg lysozyme (HEL), fused to murine C3d. HEL bearing two and three copies of C3d was 1000- and 10,000-fold more immunogenic, respectively, than HEL alone. Thus, C3d is a molecular adjuvant of innate immunity that profoundly influences an acquired immune response.
引用
收藏
页码:348 / 350
页数:3
相关论文
共 21 条
[1]
CHARACTERIZATION OF THE MESSENGER-RNA AND CLONED CDNA SPECIFYING THE 3RD COMPONENT OF MOUSE COMPLEMENT [J].
DOMDEY, H ;
WIEBAUER, K ;
KAZMAIER, M ;
MULLER, V ;
ODINK, K ;
FEY, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7619-7623
[2]
ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE [J].
ENGEL, P ;
ZHOU, LJ ;
ORD, DC ;
SATO, S ;
KOLLER, B ;
TEDDER, TF .
IMMUNITY, 1995, 3 (01) :39-50
[3]
CURRENT CONCEPTS IN IMMUNOLOGY - THE ALTERNATIVE PATHWAY OF COMPLEMENT - A SYSTEM FOR HOST-RESISTANCE TO MICROBIAL INFECTION [J].
FEARON, DT ;
AUSTEN, KF .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (05) :259-263
[4]
FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.iy.13.040195.001015
[5]
ALTERED IMMUNOGLOBULIN EXPRESSION AND FUNCTIONAL SILENCING OF SELF-REACTIVE LYMPHOCYTES-B IN TRANSGENIC MICE [J].
GOODNOW, CC ;
CROSBIE, J ;
ADELSTEIN, S ;
LAVOIE, TB ;
SMITHGILL, SJ ;
BRINK, RA ;
PRITCHARDBRISCOE, H ;
WOTHERSPOON, JS ;
LOBLAY, RH ;
RAPHAEL, K ;
TRENT, RJ ;
BASTEN, A .
NATURE, 1988, 334 (6184) :676-682
[6]
SUPPRESSION OF THE IMMUNE-RESPONSE BY A SOLUBLE COMPLEMENT RECEPTOR OF LYMPHOCYTES-B [J].
HEBELL, T ;
AHEARN, JM ;
FEARON, DT .
SCIENCE, 1991, 254 (5028) :102-105
[7]
INVIVO INHIBITION OF THE ANTIBODY-RESPONSE BY A COMPLEMENT RECEPTOR SPECIFIC MONOCLONAL-ANTIBODY [J].
HEYMAN, B ;
WIERSMA, EJ ;
KINOSHITA, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :665-668
[8]
THE IMMUNE-SYSTEM EVOLVED TO DISCRIMINATE INFECTIOUS NONSELF FROM NONINFECTIOUS SELF [J].
JANEWAY, CA .
IMMUNOLOGY TODAY, 1992, 13 (01) :11-16
[9]
KINOSHITA T, 1988, J IMMUNOL, V140, P3066
[10]
KROP I, IN PRESS EUR J IMMUN